Descripción de la empresa
CIMG Inc. operates within the consumer defensive sector, specifically focusing on the packaged foods industry, where it provides a range of consumer food and beverage products including maca peptide coffee, noni, purified powder, and wine. The company distributes these items to wholesale distributors such as grocery stores, convenience stores, and vending machine operators, positioning itself in a market that historically offers stability against economic downturns. As of the latest data, the entity operates with a market capitalization of $3.45M and employs 13 individuals to execute its business model. These financial figures indicate that CIMG Inc. is a micro-cap company with limited scale, suggesting that its operations are likely concentrated in specific regional markets or niche product categories rather than having a broad national footprint. The revenue generated in the trailing twelve months totals $26.04M, which, when viewed alongside the minimal employee count, highlights a highly leveraged operational model or significant reliance on third-party manufacturing and distribution channels to achieve sales volume.
Salud financiera
The company reported a revenue of $26.04M for the trailing twelve months, yet this gross income was offset by a net income of -$22,824,620 and an EBITDA of -$5,578,624, revealing a severe disconnect between top-line sales and bottom-line profitability. The substantial gap between the positive revenue and the deeply negative net income indicates a cost structure where operating expenses, likely including heavy marketing costs or manufacturing overhead, consume nearly the entirety of sales revenue. Despite the negative earnings, the company generated a free cash flow of $6.89M, which suggests a degree of financial flexibility provided by capital efficiency in operations or significant non-cash charges that do not impact cash burn. However, the liquidity position is constrained by a cash balance of only $45,356 against total debt obligations of $459,209, creating a precarious short-term solvency scenario. The debt-to-equity ratio stands at 0.81, while the current ratio is reported at 0.32, a metric that indicates the company possesses significantly fewer current assets than current liabilities, pointing to potential liquidity challenges in meeting immediate obligations. Profitability metrics are equally distressed, with a gross margin of -2.7%, an operating margin of -12.4%, and a profit margin of -87.6%, all of which demonstrate that the company is losing money on every dollar of sales and struggling to cover its core operational costs. Furthermore, the return on equity is -78.9% and the return on assets is -9.7%, metrics that reveal management has been ineffective at generating shareholder value or utilizing asset base to produce profits, resulting in a destruction of equity value over the trailing period.
Evaluación de valoración
Valuation multiples for CIMG Inc. are not available in the traditional sense, as the P/E ratio (TTM) and forward P/E are both listed as N/A due to the company's negative earnings. The absence of a positive trailing P/E implies that standard earnings-based valuation models cannot be applied, forcing reliance on alternative metrics to assess the stock's relative value. The price-to-book ratio is calculated at 0.06, which indicates that the market is valuing the company at less than one-tenth of its book value, a common characteristic for distressed firms or those with significant intangible assets not captured on the balance sheet. Additionally, the price-to-sales ratio stands at 0.13 and the EV/EBITDA is -0.50, suggesting that the market is pricing the stock based on revenue multiples rather than earnings power, though the negative EV/EBITDA reflects the underlying loss-making nature of the business. The stock has exhibited extreme volatility, trading between a 52-week high of $13.84 and a 52-week low of $0.05, with the current price trading at a level that is difficult to quantify precisely without the exact current share price, but the wide range suggests significant speculation. The beta is listed as N/A, which means there is no historical data available to quantify the stock's volatility relative to the broader market, likely due to the low liquidity and trading volume associated with its micro-cap status.
Growth & Income
The company experienced a revenue growth of 68901.0% year-over-year, a figure that appears anomalously high and may result from a change in fiscal year-end timing or the inclusion of one-time sales, while the earnings growth is N/A due to the negative net income. The disparity between the astronomical revenue growth figure and the lack of earnings growth highlights that top-line expansion has not translated into profitability, implying that the revenue increase is not sustainable or is being eroded by costs. As a non-dividend payer, the company has a dividend yield of N/A and a payout ratio of 0.0%, indicating that it does not distribute cash to shareholders but instead retains all cash flows, although in this case, the retained earnings are insufficient to cover losses. This profile suggests the management is prioritizing survival and operational restructuring over income generation, as evidenced by the inability to pay any dividends despite the nominal free cash flow. The overall growth and income profile is characterized by extreme revenue volatility and persistent losses, presenting a high-risk scenario where income is currently negative and future earnings potential remains unproven.